Snapdragon Announces New Labs in Cambridge
News Apr 04, 2016
Snapdragon Chemistry is pleased to make several significant announcements. First, Snapdragon has moved to new lab facilities at 85 Bolton Street in Cambridge, Massachusetts. Snapdragon’s corporate partner, Zaiput Flow Technologies, has also moved to the 85 Bolton Street site. This co-location will enhance the collaboration of these strategic partners and accelerate the development of advanced continuous chemical manufacturing technologies and solutions.
Snapdragon also announces completion of an investment round that enables both the significant expansion of its capabilities and technologies and the recruitment of additional top scientists in order to keep pace with the high demand for Snapdragon’s services. Snapdragon is expanding its reaction profiling and analytical capabilities to include additional in-line process analytical technologies (PAT), including real-time and automated feedback control of process parameters. Snapdragon is also expanding its computational modeling capabilities, using reaction-profiling data in order to deliver “right-first-time” reactor design.
As part of the expansion, Snapdragon has hired Dr. Eric Fang as Director of Chemistry and added both PhD and BS level chemists. Snapdragon also plans to hire additional scientists and engineers in the near future.
Finally, in recognition of his contributions to the expansion of the company and the successful fundraising round, Snapdragon is pleased to announce the election of Dr. Matthew Bio to President and CEO, succeeding the current President/CEO and Co-Founder Tim Jamison. Jamison will continue as Chairman and as scientific and technical advisor to Snapdragon. Co-founder Aaron Beeler will also continue to serve on the board of directors and as scientific and technical advisor.
Artificial Leaf Acts as a Mini Medicine FactoryNews
Using sunlight for sustainable and cheap production of, for example, medicines. The 'mini-factory' in the form of a leaf that was presented in 2016 showed that it is possible. Now researchers have come with an improved version: their 'mini-factory' is now able to keep production at the same level, irrespective of the variation in sunlight due to cloudiness or time of the day.READ MORE
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
‘Coffee Filter’ Makes Production of Cancer Drug Much CheaperNews
Making drugs cheaper doesn't always require pricey investments. What started out as a Bachelor project at TU/e laid the foundation for a much cheaper production of the promising cancer drug Z-endoxifen.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018